V NRx next week will beat gL NRx, imo. Thhis is because we are seeing V NRx is growing week to week whereas gL' is decreasing. I still don't understand why patients still buy gL or L. Must be that insurance companies and some pharmacists. Understand could be the tier system or formularies that don't cover V yet. Those responsible for revising those guidelines should act fast too. Hopefully ACC conf elevate this need.
Sam: the NRx were up over 5% with an ATH last week as compared with the previous week...the NRx for this FOUR DAY week were up AGAIN over the previous week for a new ATH...this IMO is quite significant and augers well for the stats for the present 5 day week to be also an ATH and grow new ATHs on successive weeks into the future. We are getting close to better weather in the North East, the ACC meeting and the sNDA submission and... not too far away, FDA approval for expanded indications...the future looks bright.